rediff.com

Search result for 'age-related macular degeneration'

New Delhi, May 21...

Biocon Biologics Gets USFDA Approval for Biosimilar Ophthalmology Drug

May 21, 2024 11:06
Biocon Biologics has received USFDA approval for Yesafili, a biosimilar to Eylea (aflibercept), for treating various ophthalmology conditions like age-related macular degeneration.

Read more »

Roche Pharma Launches Vision Loss Treatment: Vabysmo

March 5, 2024 20:05
Roche Pharma India launches Vabysmo (faricimab) for age-related macular degeneration and diabetic macular edema, the two leading causes of vision loss.

Read more »

New Delhi, Mar 4...

Biocon Biologics Launches Biosimilar in Canada - Yesafili

March 4, 2024 11:09
Biocon Biologics secures patent settlement, paving the way for the launch of Yesafili, a biosimilar to Eeylea (aflibercept) injection, in Canada by July 1, 2025.

Read more »

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

More »

MORE NEWS

EcoZen Raises USD...
EcoZen Raises USD 23 Million for Climate-Smart...

EcoZen, a climate-smart tech provider, secures USD 23 million in funding from...
GTDC Pays Rs 45...
GTDC Pays Rs 45 Lakh Dividend to Goa Government

Goa Tourism Development Corporation (GTDC) has paid a dividend of Rs 45 lakh to the...
Zurich Kotak...
Zurich Kotak Appoints Alok Kumar Agarwal as MD

Zurich Kotak General Insurance has appointed Alok Kumar Agarwal as Managing Director...

More »

Moneywiz Live!

ALL MONEYWIZ PAGES
rediff on the net© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback